Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects

Documenti analoghi

• Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach
  di: Michiel de Vries, et al.
  Pubblicazione: (2024)
• Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Pritelivir and Its Metabolites
  di: Katharina Erb‐Zohar, et al.
  Pubblicazione: (2024)
• Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study
  di: Chenning Zhang, et al.
  Pubblicazione: (2024)
• Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects
  di: Mengli Tian, et al.
  Pubblicazione: (2024)
• Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing
  di: Sergi Coll, et al.
  Pubblicazione: (2026)